Skip to main content
With support from students and city policy, the university’s popular residential composting program is helping turn food waste into community benefit

New research suggests that amyloid-beta (Aβ) oligomers and the vascular protein fibrinogen may, when forming a complex, contribute to Alzheimer's disease.

Kivanç Birsoy is uncovering the hidden metabolic pathways that cancer cells exploit. His work could also optimize strategies for using nutrition to improve human health.

University Health and Wellness does everything from flu shots to biosafety level 3 testing.

Scientists Quarraisha Abdool Karim and Salim S. Abdool Karim, philanthropist Marlene Hess, and Nobel-prize winner Michael W. Young were also given honorary degrees.

Study provides a model for how different enzymes unfold proteins and remove tags, solving a longstanding mystery about how the two interact.

An immersive program helps undergraduates from minority-serving institutions envision futures in research

Researchers have devised a way to visualize molecules that are very rare, very small, or hard to produce naturally—including some viruses.

Newly discovered weapons of bacterial self-defense take different approaches to achieving the same goal: preventing a virus from spreading through the bacterial population.

How a modest task force grew into a campuswide commitment to greener science and smarter operations

Mutations in FANCX appear to cause a lethal form of Fanconi anemia, a finding that sheds light on unexplained pregnancy loss and offers new avenues for genetic screening.

On Wednesday, April 30, The Rockefeller University honored members of its community who reached service milestones ranging from 10 to 45 years.

Mojsov is a research associate professor whose research led to the development of drugs for obesity and diabetes.

New findings suggest neurons have much more functional dexterity than scientists previously realized.

Ines Ibañez-Tallon is revealing how an understudied region of the brain plays an outsized role in opioid and nicotine dependence. 

Open access, peer reviewed, and co-owned, the Journal of Human Immunity represents a new business model in scientific publishing.

Mojsov is recognized for her discovery of the peptide hormone GLP-1, research that led to a new class of safe and highly effective drugs for type 2 diabetes as well as the treatment of obesity.

Kivanç Birsoy and Ekaterina Vinogradova will head projects that aim to harness and bioengineer immune cells for the early detection, prevention, and treatment of disease.

Results presented at Conference on Retroviruses and Opportunistic Infections show that two broadly neutralizing antibodies can keep HIV suppressed for months.

This bold, multi-institutional collaboration will investigate how metabolism, diet, and gut microbes shape immune responses to cancer.

A surprising mix of inherited and de novo mutations in 60 genes contribute to 10 percent of CHD cases. Many of these same mutations also contribute to neurodevelopmental disorders including autism. 

New imaging reveals a built-in safeguard that allows B cell populations to rapidly expand in germinal centers without introducing deleterious mutations.

New study demonstrates how high-affinity B cells "bank" their best traits instead of rolling the dice and risking deleterious mutations, with implications for better vaccine design.

The author of How We Learn will be presented with Rockefeller’s prestigious science writing award on March 17.

Mei, a graduate student in Sohail Tavazoie’s lab, is being honored for work showing that a commonly inherited mutation governs breast cancer metastasis and influences survival.

Jeffrey M. Friedman’s lab has discovered a mechanism to explain how leptin resistance works.

Most obese patients grow resistant to satiety signals from the hormone leptin. A new study shows that leptin sensitivity can be restored in mice, leading to weight loss.

An artist-in-residence collaborates with scientists in the Kronauer lab to reveal the unseen movements of ants.

A collaboration between Rockefeller, MSK, and Weill Cornell answers a longstanding mystery about the basic biology of the hepatitis B virus, while also proposing a novel therapy.

When placed in mice, an RNA-binding protein found only in the brains of humans changed how the animals vocalized to each other.
View
View